Ginkgolide B Induces Apoptosis via Activation of JNK and p21-Activated Protein Kinase 2 in Mouse Embryonic Stem Cells.

Hsuuw, Yan‐Der; Kuo, Tzong‐Fu; Lee, Kun‐Hsiung; Liu, Yen‐Chih; Huang, Yu‐Ting; Lai, Ching‐Yu; Chan, Wen‐Hsiung

Ginkgolide B (GKB), the major active component of Ginkgo biloba extracts, can both stimulate and inhibit apoptotic signaling. We previously showed that ginkgolide treatment of mouse blastocysts induces apoptosis, decreases cell numbers, retards the proliferation and development of mouse embryonic stem cells and blastocysts in vitro, and causes developmental injury in vivo. However, the precise molecular mechanisms underlying its actions are currently unknown. Here, our study further revealed that GKB induced apoptotic biochemical changes, including activation of JNK, caspase-3, and p21-activated protein kinase 2 (PAK2), in ESC-B5 mouse embryonic stem cells. Treatment of ESC-B5 cells with a JNK-specific inhibitor (SP600125) reduced GKB-induced activation of both JNK and caspase-3, indicating that JNK activity is required for GKB-induced caspase activation. Experiments using caspase-3 inhibitors and antisense oligonucleotides against PAK2 showed that caspase-3 activation is required for PAK2 activation and both of these activations are required for GKB-induced apoptosis in ESC-B5 cells.

EMBRYONIC stem cells; HUMAN cloning; PROTEIN kinases; GINKGO; GYMNOSPERMS

Annals of the New York Academy of Sciences, 2009, Vol 1171, p501

0077-8923

Academic Journal

10.1111/j.1749-6632.2009.04691.x